Cynthia Sirard Leap Therapeutics, Inc. (LPTX) insider trading activity
Cynthia Sirard is Chief Medical Officer of LEAP THERAPEUTICS, INC.. Currently has a direct ownership of 27,500 shares of LPTX, which is worth approximately $8,800. The most recent transaction as insider was on Mar 28, 2025, when has been sold 22,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
27.5K
450.0%
3M change
450.0%
12M change
Total Value Held
$8,800
Cynthia Sirard Transaction History
CS
Cynthia Sirard
Chief Medical Officer
Cambridge, MA